Sernivo
NDC Package 69482-800-99

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Sernivo is a medication used to treat a type of skin condition (plaque psoriasis). Marketed by Encore Dermatology Inc., this product is identified by NDC 69482-800 and is authorized under FDA application NDA208079.

Identification & Billing

NDC Package Code
69482-800-99
Package Description
1 BOTTLE, SPRAY in 1 CARTON / 120 g in 1 BOTTLE, SPRAY
Product Code
69482-800
11-Digit Billing Format
69482080099
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

Clinical Specifications

Proprietary Name
Sernivo
Dosage Form
-
Usage Information
This medication is used to treat a type of skin condition (plaque psoriasis). Betamethasone reduces the swelling, itching, and redness that may occur with plaque psoriasis. This medication is a strong corticosteroid.

Regulatory & Marketing

Labeler Name
Encore Dermatology Inc.
FDA Application #
NDA208079
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-01-2020
End Marketing Date
02-13-2025
Listing Expiration
02-13-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69482-800-99 identifies a specific commercial package of 1 bottle, spray in 1 carton / 120 g in 1 bottle, spray of Sernivo, labeled by Encore Dermatology Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Encore Dermatology Inc. on January 01, 2020. The current certification is valid through February 13, 2025.

What are the primary indications for this medication?

This medication is used to treat a type of skin condition (plaque psoriasis). Betamethasone reduces the swelling, itching, and redness that may occur with plaque psoriasis. This medication is a strong corticosteroid.

How is this Encore Dermatology Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69482080099. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69482-800-99
11-Digit CMS (5-4-2)
69482-0800-99

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.